Clear the Plaque. Restore the Mind.
Advanced Help for Amyloid Plaquing Starts at Alzheimer’s Treatment Centers of America
If you’ve been told that amyloid plaques may be affecting your memory, thinking, or focus—there’s new hope.
At Alzheimer’s Treatment Centers of America, we use AI-driven diagnostics and precision medicine to identify and treat the complex causes of cognitive decline, including amyloid buildup in the brain.
Our goal is simple: to clear what’s blocking your brain and restore what makes you… you.
Why Amyloid Plaques Matter
Amyloid plaques are abnormal protein deposits that disrupt communication between brain cells — a hallmark of Alzheimer’s disease.
Over time, they contribute to memory loss, confusion, and cognitive decline.
But now, breakthrough therapies can help reduce their impact and support brain recovery.
See What’s Really Happening Inside Your Brain — with BEAM™
BEAM™ (Brain Evaluation and Mapping) is one of the most advanced tools available for understanding your brain health.
Using a combination of EEG brainwave analysis and cognitive testing, BEAM™ creates a detailed map of how your brain is functioning — including areas affected by amyloid buildup or inflammation.
Unlike basic memory tests, BEAM™ provides quantifiable biomarkers that show:
- How well your brain communicates between regions
- Where disruptions may be caused by amyloid plaques
- Whether treatments are slowing, halting, or reversing decline
BEAM™ allows our medical team to see what other tests miss, guiding a truly personalized care plan and tracking your progress over time.
“BEAM™ helps us measure real improvement — not just memory tests, but biological recovery.”
— Dr. George Moricz, MD, Chief Medical Officer
Book Your Free Brain Health Consultation With Report
How ATCA Targets Amyloid Plaque
We combine AI-powered precision medicine with over 50 innovative treatment modalities to support brain detoxification and healing.
Our most effective approaches include:
Therapeutic Plasma Exchange (TPE)
A non-surgical, hospital-grade treatment that helps filter toxins and amyloid proteins from your blood, promoting cleaner circulation and a healthier brain environment. TPE may help improve memory, mental clarity and overall brain function.x
TB006 Clinical Treatment
A cutting-edge antibody therapy that targets Galectin-3, a key driver of inflammation and plaque formation in the brain. Offered exclusively through FDA-approved clinical trials at ATCA, TB006 may slow progression and restore cognitive function.
Brain Mapping with BEAM™
We use advanced brainwave and cognitive testing to measure amyloid-related damage and track improvement over time — ensuring every treatment is customized to your biology.
Why Choose ATCA
Why Patients Choose ATCA
In an observational study of our AI-protocol, 80% of patients had no further decline in their mild cognitive impairment.
Don’t Wait — Early Treatment Matters
Amyloid plaques form silently — but their effects aren’t. By acting early, you can protect memory, restore clarity, and slow further damage.
Our combination of BEAM™ diagnostics and targeted therapies gives you answers and options that standard care simply doesn’t provide.
Every month you wait could mean more irreversible damage.
Now is the time to act — and reclaim hope.